UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 111

Sortiert nach

Lipoproteins, Cholesterol, and Atherosclerotic Cardiovascular Disease in East Asians and Europeans

Journal of Atherosclerosis and Thrombosis, 2023/11/01, Vol.30(11), pp.1525-1546

2023

Volltextzugriff (PDF)

How Can We Identify Very High-Risk Heterozygous Familial Hypercholesterolemia?

Journal of Atherosclerosis and Thrombosis, 2022/06/01, Vol.29(6), pp.795-807

2022

Volltextzugriff (PDF)

Can remnant cholesterol (triglyceride-rich lipoproteins) reclassify estimated risk of atherosclerotic cardiovascular disease?

Current opinion in endocrinology, diabetes, and obesity, 2023-04, Vol.30 (2), p.128

2023

Volltextzugriff (PDF)

Combined evaluation of plasma B-type natriuretic peptide and urinary liver-type fatty acid-binding protein/creatinine ratio is related to worsening renal function in patients undergoing elective percutaneous coronary intervention

Clinical and experimental nephrology, 2021-12, Vol.25 (12), p.1319-1328

2021

Volltextzugriff (PDF)

Characterization of Polyvascular Disease in Heterozygous Familial Hypercholesterolemia: Its Association With Circulating Lipoprotein(a) Levels

Journal of the American Heart Association, 2022-08, Vol.11 (16), p.e025232-e025232

2022

Volltextzugriff (PDF)

Asymptomatic Intracranial Artery Stenosis/Occlusion in Heterozygous Familial Hypercholesterolemia: Its Frequency and Implications for Cerebrovascular and Cardiovascular Events

Journal of the American Heart Association, 2024-08, Vol.13 (15), p.e033972

2024

Volltextzugriff (PDF)

Patients With LDLR and PCSK9 Gene Variants Experienced Higher Incidence of Cardiovascular Outcomes in Heterozygous Familial Hypercholesterolemia

Journal of the American Heart Association, 2021-02, Vol.10 (4), p.e018263

2021

Volltextzugriff (PDF)

Effect of Eicosapentaenoic Acid/Docosahexaenoic Acid on Coronary High-Intensity Plaques Detected Using Noncontrast T1-weighted Imaging: The AQUAMARINE EPA/DHA Randomized Study

Journal of Atherosclerosis and Thrombosis, 2024/02/01, Vol.31(2), pp.122-134

2024

Volltextzugriff (PDF)

Substantially Elevated Atherosclerotic Risks in Japanese Severe Familial Hypercholesterolemia Defined by the International Atherosclerosis Society

JACC. Asia, 2021-09, Vol.1 (2), p.245-255

2021

Volltextzugriff (PDF)

Internal Mammary Artery Injury Related to Chest Compressions in a Patient with Post-cardiac Arrest Syndrome

Internal Medicine, 2016, Vol.55(10), pp.1299-1303

2016

Volltextzugriff (PDF)

Coronary artery ectasia: Importance of its risk stratification and management

International journal of cardiology, 2021-01, Vol.322, p.43-44

2021

Volltextzugriff (PDF)

Iliac artery stent fracture associated with hip joint flexion

Cardiovascular intervention and therapeutics, 2019-04, Vol.34 (2), p.180-181

2019

Volltextzugriff (PDF)

Remnant cholesterol, LDL cholesterol, and APOB absolute mass changes explain results of prominent and other fibrate trials

Atherosclerosis, 2024-08, Vol.395

2024

Volltextzugriff (PDF)

A possible explanation for the contrasting results of REDUCE-IT vs. STRENGTH: cohort study mimicking trial designs

European heart journal, 2021-12, Vol.42 (47), p.4807-4817

2021

Volltextzugriff (PDF)

Elevated Remnant Cholesterol Reclassifies Risk of Ischemic Heart Disease and Myocardial Infarction

Journal of the American College of Cardiology, 2022-06, Vol.79 (24), p.2383-2397

2022

Volltextzugriff (PDF)

Dual elevated remnant cholesterol and C-reactive protein in myocardial infarction, atherosclerotic cardiovascular disease, and mortality

Atherosclerosis, 2023-08, Vol.379, p.117141-117141, Article 117141

2023

Volltextzugriff (PDF)

Remnant cholesterol, LDL cholesterol, and apoB absolute mass changes explain results of the PROMINENT trial

Atherosclerosis, 2024-06, Vol.393, p.117556-117556, Article 117556

2024

Volltextzugriff (PDF)

Mass changes in remnant cholesterol and LDL cholesterol explain part of the results of gemfibrozil and non-gemfibrozil fibrate trials

Journal of internal medicine, 2024-05, Vol.295 (5), p.707-710

2024

Volltextzugriff (PDF)

Baloxavir Marboxil for Uncomplicated Influenza in Adults and Adolescents

The New England journal of medicine, 2018-09, Vol.379 (10), p.913-923

2018

Volltextzugriff (PDF)

Mineral oil and icosapent ethyl may jointly explain the between arm difference of cardiovascular risk in REDUCE-IT

European heart journal, 2021-12, Vol.42 (47), p.4867-4868

2021

Volltextzugriff (PDF)

Coronary Artery Ectasia Predicts Future Cardiac Events in Patients With Acute Myocardial Infarction

Arteriosclerosis, thrombosis, and vascular biology, 2017-12, Vol.37 (12), p.2350

2017

Volltextzugriff (PDF)

How Can We Identify Very High-Risk Heterozygous Familial Hypercholesterolemia?

Journal of Atherosclerosis and Thrombosis, 2022, pp.RV17063

2022

Volltextzugriff (PDF)

Cardiac outcomes in patients with acute coronary syndrome attributable to calcified nodule

Atherosclerosis, 2021-02, Vol.318, p.70-75

2021

Volltextzugriff (PDF)

Remnant cholesterol and low-grade inflammation jointly in atherosclerotic cardiovascular disease: implications for clinical trials

Current opinion in clinical nutrition and metabolic care, 2024-03, Vol.27 (2), p.125

2024

Volltextzugriff (PDF)

1 – 25 von 111

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(86)
Mit Volltextzugriff
(100)

Publikationsform

Sprache

Englisch
(102)
Japanisch
(37)

Erscheinungsjahr

n.n

Thema

Science & Technology
(72)
Life Sciences & Biomedicine
(59)
Humans
(32)
Cardiovascular System & Cardiology
(20)
Male
(19)
Cardiac & Cardiovascular Systems
(16)
Female
(14)
Medicine
(13)
General & Internal Medicine
(12)
Medicine, General & Internal
(11)
Case Report
(10)
Middle Aged
(10)
Peripheral Vascular Disease
(10)
Science & Technology - Other Topics
(10)
Aged
(9)
Animals
(9)
Case Reports
(9)
Risk Factors
(9)
Adult
(8)
Multidisciplinary Sciences
(8)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Lipoproteins, Cholesterol, and Atherosclerotic Cardiovascular Disease in East Asians and Europeans

How Can We Identify Very High-Risk Heterozygous Familial Hypercholesterolemia?

Can remnant cholesterol (triglyceride-rich lipoproteins) reclassify estimated risk of atherosclerotic cardiovascular disease?

Combined evaluation of plasma B-type natriuretic peptide and urinary liver-type fatty acid-binding protein/creatinine ratio is related to worsening renal function in patients undergoing elective percutaneous coronary intervention

Characterization of Polyvascular Disease in Heterozygous Familial Hypercholesterolemia: Its Association With Circulating Lipoprotein(a) Levels

Asymptomatic Intracranial Artery Stenosis/Occlusion in Heterozygous Familial Hypercholesterolemia: Its Frequency and Implications for Cerebrovascular and Cardiovascular Events

The feasibility and limitation of coronary computed tomographic angiography imaging to identify coronary lipid-rich atheroma in vivo: Findings from near-infrared spectroscopy analysis

Patients With LDLR and PCSK9 Gene Variants Experienced Higher Incidence of Cardiovascular Outcomes in Heterozygous Familial Hypercholesterolemia

Effect of Eicosapentaenoic Acid/Docosahexaenoic Acid on Coronary High-Intensity Plaques Detected Using Noncontrast T1-weighted Imaging: The AQUAMARINE EPA/DHA Randomized Study

Substantially Elevated Atherosclerotic Risks in Japanese Severe Familial Hypercholesterolemia Defined by the International Atherosclerosis Society

Internal Mammary Artery Injury Related to Chest Compressions in a Patient with Post-cardiac Arrest Syndrome

Coronary artery ectasia: Importance of its risk stratification and management

Iliac artery stent fracture associated with hip joint flexion

Remnant cholesterol, LDL cholesterol, and APOB absolute mass changes explain results of prominent and other fibrate trials

A possible explanation for the contrasting results of REDUCE-IT vs. STRENGTH: cohort study mimicking trial designs

Elevated Remnant Cholesterol Reclassifies Risk of Ischemic Heart Disease and Myocardial Infarction

Dual elevated remnant cholesterol and C-reactive protein in myocardial infarction, atherosclerotic cardiovascular disease, and mortality

Remnant cholesterol, LDL cholesterol, and apoB absolute mass changes explain results of the PROMINENT trial

Mass changes in remnant cholesterol and LDL cholesterol explain part of the results of gemfibrozil and non-gemfibrozil fibrate trials

Baloxavir Marboxil for Uncomplicated Influenza in Adults and Adolescents

Mineral oil and icosapent ethyl may jointly explain the between arm difference of cardiovascular risk in REDUCE-IT

Coronary Artery Ectasia Predicts Future Cardiac Events in Patients With Acute Myocardial Infarction

How Can We Identify Very High-Risk Heterozygous Familial Hypercholesterolemia?

Cardiac outcomes in patients with acute coronary syndrome attributable to calcified nodule

Remnant cholesterol and low-grade inflammation jointly in atherosclerotic cardiovascular disease: implications for clinical trials

Suchergebnisse filtern